A heparin binding site Arg79Cys missense mutation in the SERPINC1 gene in a Korean patient with hereditary antithrombin deficiency

Ann Clin Lab Sci. 2011 Fall;41(1):89-92.

Abstract

We describe a case of heparin binding site Arg79Cys mutation in the gene encoding antithrombin, SERPINC1, in a Korean patient with hereditary antithrombin (AT) deficiency. The patient was a 34-year-old Korean man who presented with deep vein thrombosis (DVT) in his right leg without precipitating factors. On outpatient evaluation, coagulation tests without anticoagulation revealed a decreased AT III activity level at 48%, but normal AT III antigen level at 103%, indicating type II AT deficiency. Family studies revealed that his father (62 years of age) had decreased AT activity (48%) but had normal AT antigen levels (116%), indicating that the proband had a paternally inherited type II AT deficiency. Direct sequencing of the SERPINC1 gene in the patient and his father revealed a heterozygotic missense mutation, a cytosine to thymine substitution at nucleotide position 235 in exon 2 of the SERPINC1 gene (p.Arg79Cys). To our knowledge, this is the first report of Arg79Cys heterozygote mutation in family members with venous thromboembolism.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Amino Acid Substitution / genetics*
  • Antithrombin III / genetics*
  • Antithrombin III Deficiency / genetics*
  • Asian People / genetics*
  • Base Sequence
  • Binding Sites
  • DNA Mutational Analysis
  • Female
  • Heparin / metabolism*
  • Humans
  • Male
  • Molecular Sequence Data
  • Mutation, Missense / genetics*
  • Pedigree
  • Republic of Korea

Substances

  • SERPINC1 protein, human
  • Antithrombin III
  • Heparin